Last update 26 Jul 2025

Recombinant thymosin alpha-1(Changchun Genescience)

Overview

Basic Info

Drug Type
Hormone
Synonyms-
Target
thymosin alpha 1
Action
agonists
Mechanism
thymosin alpha 1 agonists(Thymosin alpha-1 agonists)
Therapeutic Areas
Infectious DiseasesDigestive System Disorders
Active Indication-
Inactive Indication
Hepatitis B, Chronic
Originator Organization
Changchun Genescience Pharmaceuticals Co., Ltd.Changchun Genescience Pharmaceuticals Co., Ltd.
Active Organization-
Inactive Organization
Changchun Genescience Pharmaceuticals Co., Ltd.Changchun Genescience Pharmaceuticals Co., Ltd.
License Organization-
Drug Highest PhasePendingPhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Recombinant thymosin alpha-1(Changchun Genescience)
CTR20150489
/ CompletedPhase 3
注射用重组人胸腺素α1治疗慢性乙型肝炎Ⅲ期临床研究
[Translation] Phase III clinical study of recombinant human thymosin α1 for injection in the treatment of chronic hepatitis B
CTR20150468
/ CompletedPhase 2
注射用重组人胸腺素α1治疗慢性乙型肝炎II期临床研究
[Translation] Phase II clinical study of recombinant human thymosin α1 for injection in the treatment of chronic hepatitis B
100 Clinical Results associated with Recombinant thymosin alpha-1(Changchun Genescience)
Login to view more data
100 Translational Medicine associated with Recombinant thymosin alpha-1(Changchun Genescience)
Login to view more data
100 Patents (Medical) associated with Recombinant thymosin alpha-1(Changchun Genescience)
Login to view more data
100 Deals associated with Recombinant thymosin alpha-1(Changchun Genescience)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatitis B, ChronicPhase 3
China
Changchun Genescience Pharmaceuticals Co., Ltd.Changchun Genescience Pharmaceuticals Co., Ltd.
25 Aug 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free